PROMPT PHARMA CONSULTING

On average 15-30 percent of the revenues of the leading pharma companies nowadays are formed by the sales of "third party products" grouped in two categories: in-licensed and contract manufactured. This significant share in the sales revenue raises the importance of the external products in the portfolio of the pharma companies and puts a focus on the partnership for the development and on the management of the "virtual factory" in the production.

Primary location: Sofia Bulgaria